Ilan Zipkin

Ilan Zipkin is a professional based in the San Francisco Bay Area who is currently a Venture Partner at Breakout Ventures.1 He has over 500 connections on LinkedIn, indicating a strong professional network in his field.1

Professional Activities

Ilan Zipkin appears to be actively involved in the biotech and pharmaceutical industries, with a focus on innovative therapeutics:

Obesity Treatment:: He recently shared information about Supercede Therapeutics, a company developing an oral drug for obesity. This treatment has a unique mechanism that aims to increase lean muscle while reducing fat.2

Mental Health Research:: In November 2022, Zipkin announced the dosing of the first patient in a Phase 2 trial for a first-in-class vasopressin 1b (V1b) receptor antagonist, likely for the treatment of major depressive disorder.4

Personal Interests

Ilan Zipkin also shows involvement in educational initiatives:

Support for STEM Education:: He has expressed pride in featuring student interns, specifically mentioning Laylena Zipkin, a senior at UC San Diego who worked at the Boz Institute.3

Ilan Zipkin's LinkedIn profile and posts suggest that he is a well-connected professional in the venture capital and biotech sectors, with a particular interest in innovative therapeutic approaches and supporting educational initiatives in science.